Cytotheryx, Inc.
Cytotheryx is a platform technology company based in Rochester, Minnesota, focused on developing a high-quality, consistent source of primary human hepatocytes to address the critical shortage of liver cells for research and therapeutic applications. Their revolutionary bio-incubator technology allows for the expansion of liver cells up to 1000x, enabling new treatments, cures, and therapies for liver disease, liver failure, and rare diseases. They collaborate with leading institutions like Mayo Clinic, Precigen Exemplar, and Children’s Minnesota, and are committed to scientific innovation, excellence, and improving lives through biomedical research and therapeutics.
Industries
Nr. of Employees
small (1-50)
Cytotheryx, Inc.
Rochester, Minnesota, United States, North America
Products
Cryopreserved primary porcine hepatocytes (plateable)
Plateable cryopreserved porcine hepatocyte vials preserved on isolation with high post‑thaw viability and attachment efficiency suitable for long‑term metabolic assays including CYP450 induction.
Cryopreserved primary porcine hepatocytes (suspension)
Suspension‑grade cryopreserved porcine hepatocyte vials preserved on isolation for short‑term metabolic assays (2–4 h) with high post‑thaw viability.
Cryopreserved primary porcine hepatocytes (plateable)
Plateable cryopreserved porcine hepatocyte vials preserved on isolation with high post‑thaw viability and attachment efficiency suitable for long‑term metabolic assays including CYP450 induction.
Cryopreserved primary porcine hepatocytes (suspension)
Suspension‑grade cryopreserved porcine hepatocyte vials preserved on isolation for short‑term metabolic assays (2–4 h) with high post‑thaw viability.
Services
Supply of cryopreserved porcine hepatocytes (plateable and suspension)
Provision of cryopreserved primary porcine hepatocytes in plateable and suspension formats (>5M viable cells per vial) for preclinical ADME, DMPK, and toxicology applications; shipped in LN2 dry shippers.
Collaborative research and partnership engagements
Collaborative development opportunities including scientific partnerships, investor relationships, and technology‑complementing collaborations to expand hepatocyte applications and scale platform technology.
High‑health swine supply for biomedical research
Sale and supply of high‑health research swine raised in a DPF barrier facility with USDA inspection and AAALAC accreditation, with quarterly biosurveillance testing available on request.
Supply of cryopreserved porcine hepatocytes (plateable and suspension)
Provision of cryopreserved primary porcine hepatocytes in plateable and suspension formats (>5M viable cells per vial) for preclinical ADME, DMPK, and toxicology applications; shipped in LN2 dry shippers.
Collaborative research and partnership engagements
Collaborative development opportunities including scientific partnerships, investor relationships, and technology‑complementing collaborations to expand hepatocyte applications and scale platform technology.
High‑health swine supply for biomedical research
Sale and supply of high‑health research swine raised in a DPF barrier facility with USDA inspection and AAALAC accreditation, with quarterly biosurveillance testing available on request.
Expertise Areas
- Primary hepatocyte expansion and scaling
- Clinical‑grade cell manufacturing for cell therapy
- Bioartificial liver device development
- Preclinical ADME/DMPK and hepatotoxicity testing
Key Technologies
- Primary hepatocyte expansion in bio‑incubator
- Cryopreservation and LN2 cold‑chain logistics
- CYP450 metabolic activity assays
- PCR and ELISA biosurveillance testing